Metropolitan Life Insurance Company (MetLife)’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-135
| Closed | -$6.66K | – | 2395 |
|
|
2023
Q3 | $6.66K | Buy |
135
+59
| +78% | +$2.91K | ﹤0.01% | 2367 |
|
|
2023
Q2 | $5.92K | Buy |
76
+56
| +280% | +$4.36K | ﹤0.01% | 2446 |
|
|
2023
Q1 | $1.84K | Sell |
20
-62
| -76% | -$5.72K | ﹤0.01% | 2302 |
|
|
2022
Q4 | $9.72K | Hold |
82
| – | – | ﹤0.01% | 2290 |
|
|
2022
Q3 | $15K | Buy |
+82
| New | +$15K | ﹤0.01% | 2161 |
|
|
2022
Q2 | – | Sell |
-86
| Closed | -$13.4K | – | 2444 |
|
|
2022
Q1 | $13.4K | Sell |
86
-267
| -76% | -$41.5K | ﹤0.01% | 2225 |
|
|
2021
Q4 | $105K | Sell |
353
-36
| -9% | -$10.7K | ﹤0.01% | 2450 |
|
|
2021
Q3 | $224K | Sell |
389
-34
| -8% | -$19.6K | ﹤0.01% | 1985 |
|
|
2021
Q2 | $192K | Buy |
423
+44
| +12% | +$20K | ﹤0.01% | 2168 |
|
|
2021
Q1 | $204K | Buy |
379
+140
| +59% | +$75.3K | ﹤0.01% | 2007 |
|
|
2020
Q4 | $212K | Hold |
239
| – | – | ﹤0.01% | 1901 |
|
|
2020
Q3 | $151K | Buy |
+239
| New | +$151K | ﹤0.01% | 1953 |
|